United States · FDA National Drug Code directory

Ramipril

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68382-146_d155011e-1c8b-4ac2-9a2f-6d62127620c3
Product NDC: 68382-146
Form: CAPSULE
Composition / generic term: Ramipril
Labeler: Zydus Pharmaceuticals USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20101120
Source listing expiry: 20271231

Source-listed ingredients

RAMIPRIL — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 CAPSULE in 1 BOTTLE (68382-146-01) · 68382-146-01
500 CAPSULE in 1 BOTTLE (68382-146-05) · 68382-146-05
30 CAPSULE in 1 BOTTLE (68382-146-06) · 68382-146-06
90 CAPSULE in 1 BOTTLE (68382-146-16) · 68382-146-16
100 BLISTER PACK in 1 CARTON (68382-146-77) / 1 CAPSULE in 1 BLISTER PACK (68382-146-30) · 68382-146-77

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →